Stay updated with breaking news from Brian Markison. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
RVL Pharmaceuticals plc (NASDAQ:NASDAQ:RVLP) Q1 2022 Earnings Conference Call May 12, 2022 8:30 AM ET Company Participants Lisa Wilson – Investor Relations Brian Markison – Chief Executive...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
/PRNewswire/ -- Mitsubishi Logisnext Americas group, a leading North American provider and manufacturer of material handling and innovative automation and...
About Osmotica Pharmaceuticals plc Osmotica Pharmaceuticals plc (NASDAQ:OSMT) is a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations. The company has a diverse portfolio consisting of promoted and non-promoted products, several of which incorporate Osmotica's proprietary Osmodex® drug delivery system. RVL Pharmaceuticals, Inc. is the Company's ophthalmic subsidiary supporting Upneeq®. Vertical Pharmaceuticals, LLC represents the Company's diversified branded portfolio and...
Message : Required fields BRIDGEWATER, N.J., May 10, 2021 (GLOBE NEWSWIRE) -- RVL Pharmaceuticals, Inc., a subsidiary of Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica”), a fully integrated biopharmaceutical company, today announced that its ® (oxymetazoline hydrochloride ophthalmic solution), 0.1% has been selected as the winner of the “Best New Technology Solution for Drug Delivery” award in the fifth annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technolog...